SYSMEX CORPORATION, a leading manufacturer of blood testing equipment, announced that it will establish a joint venture with UK AI company ホロジェン to promote the use of blood test data. The companies will establish Saibogen in Singapore and develop AI software combining technologies and data held by both companies.
SYSMEX CORPORATION announced on the 9th that it will establish a joint venture with UK AI company ホロジェン. The joint venture aims to advance the use of blood test data and apply it to the development of new software and other products.
The newly established entity has established Saibogen in Singapore. Its paid-in capital and ownership ratio have not been disclosed. The companies are expected to develop AI that analyzes information such as blood cells in the blood to help assess an individual's condition.
ホロジェン is a UK-headquartered AI company that develops models specializing in the medical field using diagnostic data from hospitals. SYSMEX CORPORATION and ホロジェン have been conducting joint research.